The subacute period of stroke lasts approximately a month in rodents and up to 3 months in humans, and increased neuronal excitability during this phase can promote motor recovery (Cheng et al., 2014), which partly explains the differential effect on brain injury after CCR5 inhibition. This evidence concerns the gene CCR5 and Stroke.